Pharmaceutical Grade CAS 1032900-25-6 Ceritinib Raw Material Ceritinib Intermediate Ceritinib

Product Details
Customization: Available
Powder: Yes
Customized: Customized
Still deciding? Get samples of $ !
Request Sample
Diamond Member Since 2021

Suppliers with verified business licenses

Audited Supplier Audited Supplier

Audited by an independent third-party inspection agency

Management System Certification
ISO 9001, ISO 14001, GMP, HACCP
  • Pharmaceutical Grade CAS 1032900-25-6 Ceritinib Raw Material Ceritinib Intermediate Ceritinib
  • Pharmaceutical Grade CAS 1032900-25-6 Ceritinib Raw Material Ceritinib Intermediate Ceritinib
  • Pharmaceutical Grade CAS 1032900-25-6 Ceritinib Raw Material Ceritinib Intermediate Ceritinib
  • Pharmaceutical Grade CAS 1032900-25-6 Ceritinib Raw Material Ceritinib Intermediate Ceritinib
  • Pharmaceutical Grade CAS 1032900-25-6 Ceritinib Raw Material Ceritinib Intermediate Ceritinib
  • Pharmaceutical Grade CAS 1032900-25-6 Ceritinib Raw Material Ceritinib Intermediate Ceritinib
Find Similar Products
  • Overview
  • Product Description
  • Product Details
  • Application&Function
  • Specification
Overview

Basic Info.

Model NO.
D-sung Ceritinib
Certification
GMP, HSE, ISO 9001, USP, BP
Suitable for
Elderly, Adult
State
Powder
Purity
>99%
Product Name
Ceritinib
Name
Ceritinib Powder
Appearance
White Powder
Color
White
Grade
Pharmaceutical Grade
Assay
HPLC 99%
Application
Pharmaceutical
Specific
COA
Test Method
HPLC
Shelf Life
2 Years
CAS No.
1032900-25-6
Mf
C28h36cln5o3s
MW
558.14
Melting Point
720.7
Density
1.251
Transport Package
Negotiable
Specification
99%
Trademark
D-sung
Origin
Shaanxi Xi′an
Production Capacity
1000kg/Month

Product Description

Pharmaceutical Grade CAS 1032900-25-6 Ceritinib Raw Material Ceritinib Intermediate Ceritinib
Pharmaceutical Grade CAS 1032900-25-6 Ceritinib Raw Material Ceritinib Intermediate Ceritinib
Product Description
Pharmaceutical Grade CAS 1032900-25-6 Ceritinib Raw Material Ceritinib Intermediate CeritinibPharmaceutical Grade CAS 1032900-25-6 Ceritinib Raw Material Ceritinib Intermediate Ceritinib
Product Details
Pharmaceutical Grade CAS 1032900-25-6 Ceritinib Raw Material Ceritinib Intermediate Ceritinib
 
Product Name Ceritinib
Appearance White Powder
CAS No. 1032900-25-6
MF C28H36ClN5O3S
Ceritinib is a drug for the treatment of lung cancer. It is an ALK inhibitor. It was approved in April 2014 by the Food and Drug Administration for the treatment of ALK-positive metastatic non-small cell lung cancer (NSCLC) following treatment with crizotinib.
Application&Function
Pharmaceutical Grade CAS 1032900-25-6 Ceritinib Raw Material Ceritinib Intermediate Ceritinib

1.It is a tyrosine kinase inhibitor of anaplastic lymphoma kinase (ALK). It can promote the development of cancer cells by blocking the protein and inhibit the cells expressing EML4-ALK and NPM-ALK fusion protein.
2.Cerinib, a novel ALK inhibitor, is highly active in advanced patients.

Specification
Pharmaceutical Grade CAS 1032900-25-6 Ceritinib Raw Material Ceritinib Intermediate CeritinibPharmaceutical Grade CAS 1032900-25-6 Ceritinib Raw Material Ceritinib Intermediate CeritinibPharmaceutical Grade CAS 1032900-25-6 Ceritinib Raw Material Ceritinib Intermediate Ceritinib
Pharmaceutical Grade CAS 1032900-25-6 Ceritinib Raw Material Ceritinib Intermediate CeritinibPharmaceutical Grade CAS 1032900-25-6 Ceritinib Raw Material Ceritinib Intermediate CeritinibPharmaceutical Grade CAS 1032900-25-6 Ceritinib Raw Material Ceritinib Intermediate Ceritinib
Pharmaceutical Grade CAS 1032900-25-6 Ceritinib Raw Material Ceritinib Intermediate Ceritinib
 

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier